Table 2.
Total number of consultations provided by general practitioners per population
| No. of consultations per 100,000 populationa per day (95% CI) | ||||
|---|---|---|---|---|
| 2019 | 2020 | Difference between 2020 and 2019, p-value | Difference within 2020, p-value | |
| C50 | ||||
| Period I-III | 4.69 (4.57; 4.80) | 4.87 (4.76; 4.99) | 0.18 (0.02; 0.35), 0.025 | |
| Period I | 4.81 (4.63; 4.99) | 5.12 (4.94; 5.31) | 0.32 (0.06; 0.57), 0.014 | |
| Period II | 4.49 (4.30; 4.69) | 4.12 (3.93; 4.30) | −0.38 (− 0.64; − 0.11), 0.005 | |
| Period III | 4.75 (4.52; 4.98) | 5.46 (5.22; 5.71) | 0.71 (0.38; 1.04), < 0.001 | |
| Period II vs Period I | −1.01 (−1.27; −0.75), < 0.001 | |||
| Period III vs Period II | 1.34 (1.04; 1.65), < 0.001 | |||
| Period III vs Period I | 0.33 (0.03; 0.64), 0.031 | |||
| C61 | ||||
| Period I-III | 5.18 (5.05; 5.31) | 5.39 (5.26; 5.53) | 0.22 (0.03; 0.41), 0.022 | |
| Period I | 5.39 (5.19; 5.61) | 5.95 (5.73; 6.17) | 0.55 (0.25; 0.85), < 0.001 | |
| Period II | 4.97 (4.75; 5.19) | 4.24 (4.03; 4.45) | −0.73 (− 1.03; − 0.43), < 0.001 | |
| Period III | 5.09 (4.83; 5.36) | 6.02 (5.74; 6.31) | 0.93 (0.54; 1.31), < 0.001 | |
| Period II vs Period I | −1.71 (−2.01; − 1.41), < 0.001 | |||
| Period III vs Period II | 1.78 (1.43; 2.13), < 0.001 | |||
| Period III vs Period I | 0.07 (−0.29; 0.43), 0.703 | |||
| E10, E11 | ||||
| Period I-III | 19.67 (19.49; 19.84) | 19.35 (19.18; 19.52) | −0.32 (− 0.56; − 0.08), 0.010 | |
| Period I | 20.42 (20.15; 20.69) | 20.82 (20.55; 21.09) | 0.40 (0.02; 0.79), 0.040 | |
| Period II | 18.64 (18.35; 18.93) | 15.82 (15.56; 16.09) | −2.82 (−3.21; − 2.42), < 0.001 | |
| Period III | 19.78 (19.44; 20.13) | 21.59 (21.23; 21.95) | 1.81 (1.31; 2.31), < 0.001 | |
| Period II vs Period I | −4.99 (−5.37; − 4.61), < 0.001 | |||
| Period III vs Period II | 5.77 (5.32; 6.21), < 0.001 | |||
| Period III vs Period I | 0.77 (0.32; 1.22), < 0.001 | |||
| I10, I20-I25, I50 | ||||
| Period I-III | 135.64 (135.20; 136.10) | 142.79 (142.30; 143.30) | 7.16 (6.51; 7.80), < 0.001 | |
| Period I | 140.63 (139.90; 141.30) | 149.77 (149.00; 150.50) | 9.15 (8.13; 10.16), < 0.001 | |
| Period II | 130.17 (129.40; 130.90) | 121.27 (120.50; 122.00) | −8.90 (−9.96; −7.84), < 0.001 | |
| Period III | 134.62 (133.70; 135.50) | 159.86 (158.90; 160.80) | 25.24 (23.92; 26.57), < 0.001 | |
| Period II vs Period I | − 28.50 (−29.54; −27.46), < 0.001 | |||
| Period III vs Period II | 38.59 (37.36; 39.81), < 0.001 | |||
| Period III vs Period I | 10.09 (8.87; 11.31), < 0.001 | |||
| J44, J45 | ||||
| Period I-III | 10.06 (9.94; 10.18) | 10.62 (10.50; 10.75) | 0.56 (0.39; 0.74), < 0.001 | |
| Period I | 10.71 (10.52; 10.91) | 10.63 (10.44; 10.83) | −0.08 (− 0.36; 0.19), 0.557 | |
| Period II | 9.70 (9.49; 9.91) | 10.70 (10.48; 10.92) | 1.00 (0.70; 1.31), < 0.001 | |
| Period III | 9.46 (9.22; 9.70) | 10.50 (10.25; 10.76) | 1.04 (0.70; 1.39), < 0.001 | |
| Period II vs Period I | 0.07 (−0.22; 0.36), 0.648 | |||
| Period III vs Period II | −0.20 (− 0.53; 0.14), 0.246 | |||
| Period III vs Period I | −0.13 (− 0.45; 0.19), 0.428 | |||
a Female and male populations for breast and prostate cancer consultations, respectively